Stocks · Health care · Pharmaceutical Preparations

Crinetics Pharmaceuticals, Inc.

CRNX Clue Score54
United States Fiscal year ends December CIK 0001658247 Results filed 3 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Coelho Rogerio Vivaldi
8 Jun 2023
Director
Buy
5,000
$22.06
$110.30K
Perceptive Advisors LLC
18 Apr 2022
10% owner
Buy indirect
157,515
$22.22
$3.50M
Perceptive Advisors LLC
25 Oct 2021
10% owner
Buy indirect
1,200,000
$19.80
$23.76M
Perceptive Advisors LLC
8 Apr 2021
10% owner
Buy indirect
304,136
$16.44
$5.00M
Richard Scott Struthers
3 Dec 2020
President & CEO
Buy
4,000
$13.10
$52.40K
Richard Scott Struthers
2 Dec 2020
President & CEO
Buy indirect
1,000
$12.60
$12.60K
Perceptive Advisors LLC
17 Apr 2020
10% owner
Buy indirect
1,071,428
$14.00
$15.00M
Alan Seth Krasner
20 Jul 2018
Chief Medical Officer
Buy
2,000
$17.00
$34.00K
Vivo Capital VIII, LLC
20 Jul 2018
10% owner
Buy indirect
153,180
$20.73
$3.18M
Vivo Capital VIII, LLC
20 Jul 2018
10% owner
Buy indirect
141,177
$17.00
$2.40M
Vivo Capital VIII, LLC
20 Jul 2018
10% owner
Buy indirect
7,137
$17.00
$121.33K
Vivo Capital VIII, LLC
20 Jul 2018
10% owner
Buy indirect
51,686
$17.00
$878.66K
Perceptive Advisors LLC
20 Jul 2018
Director
Buy indirect
400,000
$17.00
$6.80M
5AM Ventures IV, L.P.
20 Jul 2018
10% owner
Buy indirect
4,600
$17.00
$78.20K
5AM Ventures IV, L.P.
20 Jul 2018
10% owner
Buy indirect
110,400
$17.00
$1.88M

What was left out

Form 4 filings counted 272
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 20
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 52
Sales at will 86
Transactions with no price 0
Shares from compensation/vesting 22,218,718
Sales filed before the plan box existed 86
History held since 20 Jul 2018